xamoterol has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonsen, S | 1 |
| Nagatomo, T; Sasaki, K; Shibata, A; Shimada, K; Wakabayashi, H; Watanabe, K | 1 |
| Inoue, M; Ishida, Y; Kamada, T; Matsuyama, T; Ozaki, H; Sato, H; Shimazu, T; Takeda, H | 1 |
1 trial(s) available for xamoterol and Cardiomyopathies
| Article | Year |
|---|---|
Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aortic Valve Insufficiency; Cardiomyopathies; Clinical Trials as Topic; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Norepinephrine; Physical Exertion; Propanolamines; Sympathetic Nervous System; Xamoterol | 1987 |
2 other study(ies) available for xamoterol and Cardiomyopathies
| Article | Year |
|---|---|
Haemodynamic effects of ICI 118,587 in cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiac Catheterization; Cardiomyopathies; Dose-Response Relationship, Drug; Hemodynamics; Humans; Propanolamines; Xamoterol | 1984 |
Cardiomyopathic hamster hearts: long-term effects of drugs on catecholamine contents and binding characteristics of alpha 1- and beta 1-adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Catecholamines; Cricetinae; Heart; Ketanserin; Mesocricetus; Myocardium; Propanolamines; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Verapamil; Xamoterol | 1993 |